InvestorsHub Logo
Followers 44
Posts 10440
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Friday, 06/15/2018 6:27:11 AM

Friday, June 15, 2018 6:27:11 AM

Post# of 613
a different ceo handled these issues very differently..
when they found responders in Phase 2a they did Gut Bio, Hired Computer Firm to run tens of millions of calculations as to WHY they were responding, brought in DNA team to find DNA expressions and biomarkers..

THEN they applied for three Phase 2/3 Trials in Three Indications..
Trials havent started yet.and shareholders have paid the price for waiting..

but the purpose of Phase 3 is to WIN not get close..

I think VTVT has something otherwise 88 people wold not hav ecrushed Placebo group..it svery exciting..

They should follow Anavex Lead, go back, get your data points and redo a new Phase 3 with proper criteria to support Low Plasma..
It may take a year..but Dementia not going anywhere..

BP would KILL to have 88 Patients BEAT SOC at 12 months..KILL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTVT News